NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 147 filers reported holding NEKTAR THERAPEUTICS in Q2 2014. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $667,000 | -28.4% | 40,200 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $931,000 | +21.9% | 40,200 | -6.1% | 0.00% | 0.0% |
| Q1 2020 | $764,000 | +31.0% | 42,800 | +58.5% | 0.00% | 0.0% |
| Q4 2019 | $583,000 | -60.8% | 27,000 | -66.9% | 0.00% | -50.0% |
| Q3 2019 | $1,487,000 | -45.4% | 81,618 | +6.7% | 0.00% | -50.0% |
| Q2 2019 | $2,723,000 | -3.8% | 76,518 | -9.2% | 0.00% | 0.0% |
| Q1 2019 | $2,830,000 | +2.7% | 84,241 | +0.5% | 0.00% | -20.0% |
| Q4 2018 | $2,755,000 | -49.3% | 83,814 | -6.0% | 0.01% | -37.5% |
| Q3 2018 | $5,433,000 | +17.5% | 89,119 | -5.9% | 0.01% | +14.3% |
| Q2 2018 | $4,624,000 | -65.9% | 94,693 | -25.8% | 0.01% | -66.7% |
| Q1 2018 | $13,561,000 | +895.7% | 127,620 | +459.7% | 0.02% | +950.0% |
| Q4 2017 | $1,362,000 | +255.6% | 22,800 | +39.9% | 0.00% | +100.0% |
| Q1 2017 | $383,000 | +74.1% | 16,300 | -8.9% | 0.00% | – |
| Q4 2016 | $220,000 | -29.3% | 17,900 | -1.1% | 0.00% | -100.0% |
| Q3 2016 | $311,000 | +35.2% | 18,100 | -4.7% | 0.00% | – |
| Q1 2014 | $230,000 | +6.5% | 19,000 | 0.0% | 0.00% | – |
| Q4 2013 | $216,000 | +20.7% | 19,000 | +11.1% | 0.00% | – |
| Q3 2013 | $179,000 | -9.6% | 17,100 | 0.0% | 0.00% | – |
| Q2 2013 | $198,000 | – | 17,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TIRSCHWELL & LOEWY INC | 588,908 | $7,138,000 | 1.23% |
| Granahan Investment Management | 3,693,956 | $44,771,000 | 1.21% |
| NEA Management Company, LLC | 1,825,600 | $22,126,000 | 1.09% |
| FIC CAPITAL INC | 150,868 | $1,829,000 | 0.75% |
| Rhenman & Partners Asset Management AB | 181,797 | $2,203,000 | 0.66% |
| SOPHROSYNE CAPITAL LLC | 60,200 | $728,000 | 0.64% |
| HARVEY CAPITAL MANAGEMENT INC | 130,400 | $1,580,000 | 0.63% |
| Artal Group S.A. | 1,300,000 | $15,756,000 | 0.57% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 564,418 | $6,840,000 | 0.47% |
| OppenheimerFunds, Inc. | 24,400,000 | $295,728,000 | 0.35% |